文献速递头颈技术与安全CT

常规CT偶发甲状旁腺增大的机会性评估:放射科医生建议生化检查对诊断原发性甲状旁腺功能亢进症的作用

Opportunistic CT Assessment of Parathyroid Glands: Utility of Radiologist-Recommended Biochemical Evaluation for Diagnosing Primary Hyperparathyroidism.
PubMed 文献 · AJR Am J Roentgenol · 2023-03-22

本研究回顾性纳入39例无已知或疑似原发性甲状旁腺功能亢进症(PHPT)的患者,其常规CT报告中放射科医生因怀疑甲状旁腺增大而建议生化检查。仅13例(33.3%)接受了推荐检查,其中3例(23.1%)确诊PHPT,4例(30.8%)为继发性甲状旁腺功能亢进,6例(46.2%)无甲状旁腺疾病。每确诊1例PHPT需13例接受放射科建议,每4.3例接受实验室检查可确诊1例。结论认为该建议有助于识别未诊断的PHPT。

要点

  • 常规CT发现可疑甲状旁腺增大时,放射科医生建议生化检查可帮助识别未诊断的PHPT。
  • 本组中仅33.3%的患者接受了推荐的生化检查,提示依从性有待提高。
  • 接受检查者中23.1%确诊PHPT,30.8%为继发性甲状旁腺功能亢进。

关键影像表现/征象

  • 常规CT上怀疑甲状旁腺增大是触发放射科医生建议生化检查的影像学依据。
  • 3例确诊PHPT中,1例手术切除的病灶经组织病理学证实为甲状旁腺细胞增多。

诊断标准与关键数值

  • 每确诊1例PHPT需13.0例患者接受放射科医生建议,需4.3例患者接受实验室检查。
  • 接受生化检查的13例中,3例(23.1%)分类为PHPT,4例(30.8%)为继发性甲状旁腺功能亢进,6例(46.2%)无甲状旁腺疾病。

临床应用与阅片要点

  • 日常阅片发现可疑甲状旁腺增大时,可在报告中建议生化检查以评估PHPT。
  • 注意本组中仅33.3%的患者实际接受了推荐检查,需关注建议的落实。

局限性

  • 回顾性单中心研究,样本量小(39例)。
  • 放射科医生的建议基于个人判断,无正式标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Existing gaps in primary hyperparathyroidism (PHPT) diagnosis and treatment have prompted calls for systemic change in the approach to this disease. One proposed change is opportunistic assessment for enlarged parathyroid glands on routine CT examinations, to target biochemical testing to individuals most likely to have un-diagnosed PHPT. OBJECTIVE. The purpose of our study was to assess the utility of a radiologist recommendation for biochemical testing in patients with a suspected enlarged parathyroid gland on routine CT for identifying previously undiagnosed PHPT. METHODS. This retrospective study included patients without known or suspected PHPT who underwent routine CT (i.e., performed for reasons other than known or suspected parathyroid disease) between August 2019 and September 2021 in which the clinical CT report included a radiologist recommendation for biochemical testing to evaluate for possible PHPT because of a suspected enlarged parathyroid gland. Neuroradiologists at the study institution included this recommendation on the basis of individual judgment without formal criteria. The EHR was reviewed to identify patients who underwent subsequent laboratory evaluation for PHPT. An endocrine surgeon used available laboratory results and clinical data to classify patients as having PHPT, secondary hyper-parathyroidism, or no parathyroid disorder independent of the CT findings. RESULTS. The sample comprised 39 patients (median age, 68 years; 20 women, 19 men) who received the radiologist recommendation for biochemical evaluation. Of these patients, 13 (33.3%) received the recommended biochemical evaluation. Of the 13 tested patients, three (23.1%) were classified as having PHPT, four (30.8%) as having secondary hyperparathyroidism, and six (46.2%) as having no parathyroid disorder. Thus, the number of patients needing to receive a radiologist recommendation for biochemical testing per correct PHPT diagnosis was 13.0, and the number of patients needing to undergo laboratory testing per correct PHPT diagnosis was 4.3. One of the three patients classified as having PHPT underwent surgical resection of the lesion identified by CT, which was shown on histopathologic evaluation to represent hypercellular parathyroid tissue. CONCLUSION. Radiologist recommendations for biochemical testing in patients with suspected enlarged parathyroid glands on routine CT helped to identify individuals with undiagnosed PHPT. CLINICAL IMPACT. Opportunistic assessment for enlarged parathyroid glands on routine CT may facilitate PHPT diagnosis.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Bunch, Aribindi, Gorris, et al. Opportunistic CT Assessment of Parathyroid Glands: Utility of Radiologist-Recommended Biochemical Evaluation for Diagnosing Primary Hyperparathyroidism. AJR Am J Roentgenol. 2023. PMID: 36946894. doi:10.2214/AJR.23.29049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。